Global Novel Oral Anticoagulants (NOAC) Market Size, Share, and COVID-19 Impact Analysis, By Drug Type (Dabigatran, Rivaroxaban, Apixaban, Edoxaban, and Others), By Application (Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035
Premium Report Details
Base Year:
2024
Tables & Figures:
110
Pages:
225
Countries covered:
15
Companies covered::
15
Forecast CAGR:
8.68%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies